{"id":"https://genegraph.clinicalgenome.org/r/d6da05be-3244-4d0f-928c-cafaaa06a6bav1.0","type":"EvidenceStrengthAssertion","dc:description":"The *CEP104* gene is located on chromosome 1 at 1p36.32 and encodes the centrosomal protein 104kDa. The protein contains an IFT25/APC10-like domain, two coiled-coil domains, a tumor overexpressed gene domain, four zinc finger domains, and an SxIP motif. This centrosomal protein is required for ciliogenesis and for ciliary tip structural integrity. Nagase et al. (1998) screened large proteins expressed in the brain with RT-PCR analysis and detected variable expression in all human tissues examined, with highest levels in kidney and skeletal muscle. Multiple disease entities have been reported in association with this gene, including autosomal recessive Joubert syndrome and autosomal recessive intellectual developmental disorder. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was no evidence of differences in their molecular mechanism, inheritance pattern, or phenotypic spectrum. Therefore, these disease entities have been lumped into one disease entity: autosomal recessive ciliopathy: MONDO:0005308.\n\nThe *CEP104* gene was first reported in relation to autosomal recessive Joubert syndrome in 2015 (Srour et al., PMID: 26477546). Patients with *CEP104* gene variants have been reported to have a distinctive cerebellar and brain stem malformation (known as the molar tooth sign), hypotonia, and developmental delays which are the three primary features of Joubert syndrome. In addition, individuals with *CEP104* variants have also been reported to have oculomotor apraxia and intellectual disability. \nAt least 9 variants (nonsense, frameshift, splice site) have been reported in 9 probands across 4 publications (PMIDs: 26477546, 31625690, 34196201, 35359234 included in this curation). The mechanism of pathogenicity is known to be loss of function. A maximum score of 12 pts. genetic evidence was reached, considering case-level data and segregation data. \n\nThis gene-disease relationship is also supported by expression studies, functional studies, in vitro assays in non-patient cells, and animal models. The scored expression data include the detection of cloned *CEP104* (known as Glybp) in rat cortex, hippocampus, cerebellum, and brainstem tissue (Kumar et al., PMID: 7488117). In addition, another expression study noted cloned human *CEP104* (known as KIAA0562) in all human tissues examined, with highest levels in kidney and skeletal muscle (Nagase et al., PMID: 9628581). The scored functional evidence involves RNAi experiments with *CEP104*-depleted cultures of human RPE1 retinal pigment epithelial cells to demonstrate a loss of *CEP104* staining at the tip of the primary cilium and daughter centriole, significant reduction in cilia formation, and significant reduction in length of cilia which supports the hypothesis that *CEP104* is required for ciliogenesis (Satish Tammana, et al., PMID: 23970417). Frikstad et al. showed that *CEP104* silencing in zebrafish causes cilia-related manifestations, including a shortened cilia in Kupffer's vesicle, heart laterality, and cranial nerve development defects. This study also completed in vivo and in vitro analyses of *CEP104* and its interaction with another Joubert syndrome-associated cilia tip protein, CSPP1. The loss of *CEP104* or CSPP1 in human cells leads to defective Hedgehog signaling in cilia (Frikstad et al., PMID: 31412255). A total of 4.5 pts. experimental evidence was reached.\n\nIn summary, there is definitive evidence supporting the relationship between *CEP104* and autosomal recessive ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date May 13th, 2024 (SOP Version 11). \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d6da05be-3244-4d0f-928c-cafaaa06a6ba","GCISnapshot":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2025-01-28T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2025-02-04T18:11:23.800Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e313b44-d3a6-4087-89d6-62123d4196b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/258f9d82-3192-4ae8-86e5-12533a444cee","type":"EvidenceLine","dc:description":"Upgrade due to functional evidence","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/258f9d82-3192-4ae8-86e5-12533a444cee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"qPCR and western blot analysis showed significantly reduced levels of CEP104 transcripts and protein in patients compared to heterozygous or negative family members","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/258f9d82-3192-4ae8-86e5-12533a444cee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34196201","allele":{"id":"https://genegraph.clinicalgenome.org/r/9aafd312-6835-46ad-b99c-e2e2ec497769","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.2356_2357insTT (p.Cys786PhefsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580062510"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/1e313b44-d3a6-4087-89d6-62123d4196b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34196201","rdfs:label":"8800138","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9aafd312-6835-46ad-b99c-e2e2ec497769"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"developmental delay","phenotypes":"obo:HP_0001249","previousTesting":true,"previousTestingDescription":"Whole exome testing","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/258f9d82-3192-4ae8-86e5-12533a444cee_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/3f652564-7aba-4d3c-b754-20e01edd9c6b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d775e6a9-6bfa-46eb-a210-8043cad3e80f","type":"EvidenceLine","dc:description":"Down scored splice variant since it is unknown to be in cis or in trans and gave 2 points overall ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d775e6a9-6bfa-46eb-a210-8043cad3e80f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","allele":{"id":"https://genegraph.clinicalgenome.org/r/8882f863-7519-4126-ba21-bce200ee6f07","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.2572-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351564"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/607dc741-1ec8-43c2-adbe-858e1a8f7798","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/607dc741-1ec8-43c2-adbe-858e1a8f7798_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7ce670b-8662-405f-8187-58645771024f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.496C>T (p.Arg166Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351420"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3f652564-7aba-4d3c-b754-20e01edd9c6b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","rdfs:label":"GeneDx01","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a7ce670b-8662-405f-8187-58645771024f"},{"id":"https://genegraph.clinicalgenome.org/r/8882f863-7519-4126-ba21-bce200ee6f07"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002419","obo:HP_0001263","obo:HP_0000657"],"previousTesting":true,"previousTestingDescription":"Whole exome sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d775e6a9-6bfa-46eb-a210-8043cad3e80f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/607dc741-1ec8-43c2-adbe-858e1a8f7798_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/dbe5b2d4-d497-4d4b-9074-4e8b2d975e8d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32c8bcbd-36fe-475a-ac98-4c154c3659c6","type":"EvidenceLine","dc:description":"Homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32c8bcbd-36fe-475a-ac98-4c154c3659c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","allele":{"id":"https://genegraph.clinicalgenome.org/r/015ee2bf-ea97-47d5-9c3a-349d268668f4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.735+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351558"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/dbe5b2d4-d497-4d4b-9074-4e8b2d975e8d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","rdfs:label":"1763.618","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/015ee2bf-ea97-47d5-9c3a-349d268668f4"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002419","obo:HP_0001263","obo:HP_0001252","obo:HP_0000657"],"previousTesting":true,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/32c8bcbd-36fe-475a-ac98-4c154c3659c6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc97071c-36e3-4131-aa2e-f65e3f251d05_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34196201","rdfs:label":"M9100012","estimatedLodScore":1.58,"family":{"id":"https://genegraph.clinicalgenome.org/r/dc97071c-36e3-4131-aa2e-f65e3f251d05","type":"Family","rdfs:label":"M9100012","member":{"id":"https://genegraph.clinicalgenome.org/r/60f44689-d56f-48f3-80ad-55ce6a85be8c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34196201","rdfs:label":"II:4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b468123d-abe5-4e30-8708-49569f4afd52","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.1901dup (p.Leu634PhefsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA521016721"}},"firstTestingMethod":"Exome sequencing","previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7245559e-b09c-4304-bda0-af73f4741b61_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34196201","allele":{"id":"https://genegraph.clinicalgenome.org/r/b468123d-abe5-4e30-8708-49569f4afd52"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001263","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/60f44689-d56f-48f3-80ad-55ce6a85be8c"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f33c9fa5-a1d5-4cdd-a293-0a6f346f4040_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7f1c881-114b-46c4-814c-c00d8fc2a8f2","type":"EvidenceLine","dc:description":"Homozygous null variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7f1c881-114b-46c4-814c-c00d8fc2a8f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35359234","allele":{"id":"https://genegraph.clinicalgenome.org/r/38f05c3b-ec8e-4202-b417-2418f4585495","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.643C>T (p.Arg215Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA551860"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/f33c9fa5-a1d5-4cdd-a293-0a6f346f4040","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35359234","rdfs:label":"RG971228","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/38f05c3b-ec8e-4202-b417-2418f4585495"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0001263","obo:HP_0001251","obo:HP_0001249"],"previousTesting":true,"previousTestingDescription":"Whole exome sequencing","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7f1c881-114b-46c4-814c-c00d8fc2a8f2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/60f44689-d56f-48f3-80ad-55ce6a85be8c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7245559e-b09c-4304-bda0-af73f4741b61","type":"EvidenceLine","dc:description":"Upgraded due to functional data","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7245559e-b09c-4304-bda0-af73f4741b61_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"qPCR and western blot analysis showed significantly reduced levels of CEP104 transcripts and protein in patients compared to heterozygous or negative family members","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7245559e-b09c-4304-bda0-af73f4741b61_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/60f44689-d56f-48f3-80ad-55ce6a85be8c"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/495abaa3-1b1f-4934-ae2a-e4b9833fec68_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ffb5c87-3365-4190-b512-1065dd82d200","type":"EvidenceLine","dc:description":"Homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ffb5c87-3365-4190-b512-1065dd82d200_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0192331-f03a-44f5-ac6f-77f932c12f27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014704.4(CEP104):c.1328_1329insT (p.Tyr444LeufsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351512"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/495abaa3-1b1f-4934-ae2a-e4b9833fec68","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26477546","rdfs:label":"842629","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c0192331-f03a-44f5-ac6f-77f932c12f27"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0002419","obo:HP_0000657","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"Exome capture and paired-end 100 bp sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9ffb5c87-3365-4190-b512-1065dd82d200_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82f6da29-087b-460f-8508-826c8d3aa1d1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0f2708f-2296-467c-80a9-cf0e2fa4f3e3","type":"Finding","dc:description":"cilia-related manifestations observed in the zebrafish included shortened cilia in Kupffer’s vesicle, heart laterality, and cranial nerve development defects. Joubert syndrome is known as a ciliopathy and patients primarily present with abnormal brain development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31412255","rdfs:label":"CEP104 silencing in zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c62ba9bc-eaca-4948-b632-1f1ce1a6a060","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0d1f5fc-fa24-4b88-bd95-6ef4b336e2fb","type":"FunctionalAlteration","dc:description":"Immunofluorescence analysis showed that the amount of CEP104 was highly reduced at both mother and daughter centrioles in siRNA-treated non-ciliated retinal pigment epithelial cells compared with centriolar localization seen in mock-transfected cells. Staining of CEP104 at the tip of the primary cilium and the daughter centriole was completely lost in the depleted cells compared with the staining observed at the tip and daughter centriole in mock-transfected cells (Fig. 8B). The ability of cells to grow cilia was significantly reduced in CEP104-depleted cultures: only 23.7±0.4% of the depleted cells formed cilia, compared with 85.6±3.2% in mock-transfected cells (Fig. 8C). Finally, the length of the cilia that did form in the CEP104-knockdown culture was significantly reduced when compared with mock-transfected cells. The average length of the cilia in CEP104-depleted cells was ∼3.0 µm (3.04±0.69 µm; n = 40) compared with ∼5.4 µm (5.39±0.8 µm; n = 53) in mock-transfected cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23970417","rdfs:label":"RNA interference experiments"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/be550486-4da7-4de4-9db4-6f5cdb98ff39_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/754e47b9-77cf-4d8d-8832-20ed15e33b65","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2049f5bc-69f0-4017-b0e1-2e468bd3e48e","type":"Finding","dc:description":"CEP104 interacts with CSPP1 at the tip of the primary cilium to regulate cilia length and CEP104 or CSPP1 loss in human cells leads to defective Hedgehog signaling.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31412255","rdfs:label":"CSPP1 interaction with CEP104","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dd234660-cb57-459c-b2a3-031f17fc8b24","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7282cde6-2858-4717-bb05-cf31ad828ed8","type":"Finding","dc:description":"They cloned human CEP104, which they called KIAA0562. The predicted 925-amino acid protein shares significant homology with rat Glybp. RT-PCR analysis detected variable expression in all human tissues examined, with highest levels in kidney and skeletal muscle and lowest levels in testis and spleen.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9628581","rdfs:label":"Radiation hybrid analysis","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e562e27-65fe-4802-ba2a-48b2e8692a4a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f96557d-65c0-4b32-9525-c9e27edb0723","type":"Finding","dc:description":"Broad Institute online GTEx Portal noting gene expression in varying brain tissue types","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7488117","rdfs:label":"Northern blot analysis","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":9895,"specifiedBy":"GeneValidityCriteria11","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/jjjn3T8t-VE","type":"GeneValidityProposition","disease":"obo:MONDO_0005308","gene":"hgnc:24866","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_be550486-4da7-4de4-9db4-6f5cdb98ff39-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}